CN116648138A - Lactam composition and use - Google Patents

Lactam composition and use Download PDF

Info

Publication number
CN116648138A
CN116648138A CN202180081479.4A CN202180081479A CN116648138A CN 116648138 A CN116648138 A CN 116648138A CN 202180081479 A CN202180081479 A CN 202180081479A CN 116648138 A CN116648138 A CN 116648138A
Authority
CN
China
Prior art keywords
composition
lactam
solvent
ethyl
lactate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180081479.4A
Other languages
Chinese (zh)
Inventor
N·J·布朗比尔
J·C·奥基夫
N·J·帕里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever IP Holdings BV
Original Assignee
Unilever IP Holdings BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever IP Holdings BV filed Critical Unilever IP Holdings BV
Publication of CN116648138A publication Critical patent/CN116648138A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00Disinfectants; Antimicrobial compounds or mixtures thereof

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • General Health & Medical Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Toxicology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention relates to a composition comprising: (a) 0.0001-5 wt% of a lactam; and (b) 1-80 wt% solvent; wherein the composition has a pH of 4 to 6.50; wherein the lactam is selected from the following formulas. The invention also relates to a method of treating a surface to improve the resistance of the surface to bacterial fouling; and also to the use of a combination of a solvent in a lactam composition and a pH of 4 to 6.50 applied to the composition to improve the solubility and stability of the lactam in the composition.

Description

Lactam composition and use
Technical Field
The present invention relates to improvements in the hygiene field, in particular to compositions comprising lactams, which exhibit improved lactam solubility and stability.
Background
Sanitation, particularly inhibition of bacterial species, is important to consumers.
Lactams are known as inhibitors of bacterial species. They may be applied to surfaces to inhibit bacterial species.
It is desirable to improve the usability of lactams and to provide formulations that exhibit improved lactam solubility and stability.
Disclosure of Invention
We have found that by formulating a composition comprising a lactam in combination with a solvent at a pH of 4-6.50, the resulting formulation exhibits improved solubility and stability of the lactam.
In a first aspect, the present invention relates to a composition comprising: -
(a) 0.0001 to 5 wt%, preferably 0.0001 to 2.5 wt%, more preferably 0.0001 to 1 wt%, and even more preferably 0.001 to 1 wt% of a lactam; and
(b) 0.5 to 95 wt%, preferably 0.5 to 90 wt%, more preferably 0.5 to 80 wt% of a solvent;
wherein the composition has a pH of 4 to 6.50, preferably a pH of 4 to 6.25, more preferably a pH of 4.50 to 6.00;
wherein the lactam is selected from the group consisting of:
and +.>
Preferably the pH is 4-5.40, more preferably 4.50-5.40.
More preferably, the lactam is selected from:
and/or +.>
Most preferably, the lactam is:
(4-chlorophenyl) -5-methylene-pyrrol-2-one.
Preferably, the lactam is delivered from a water-based composition, preferably it comprises 0.1 to 98 wt%, preferably 0.5 to 80 wt%, more preferably 1 to 75 wt% water.
The solvent is selected from: an alcohol; levulinate derivatives; lactic acid ester derivatives; and a solvent having a dielectric constant of 15 or more, preferably the solvent is selected from the group consisting of: alcohols, levulinate derivatives; and lactate derivatives; more preferably the solvent is selected from: levulinate derivatives and lactate derivatives.
Preferred examples of solvents are: alcohols, preferably C1-C4 alcohols, more preferably ethanol; lactate derivatives, preferably ethyl lactate and/or butyl lactate; levulinate derivatives, preferably 2-methyltetrahydrofuran, ethyl levulinate and/or ethyl Levulinate Glycerol Ketal (LGK); and a solvent having a dielectric constant of 15 or more, preferably Dimethylsulfoxide (DMSO).
Preferably, the solvent is selected from: ethanol; ethyl lactate, butyl lactate; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
Preferably, the solvent is selected from: levulinate derivatives; and lactate derivatives.
Most preferably, the solvent is selected from: ethyl lactate, butyl lactate; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
The solvent is present at a level of 0.5 to 95 wt%, preferably 0.5 to 90 wt%, more preferably 0.5 to 80 wt%. The solvent may be present at a minimum level of 0.5 wt%, 0.75 wt%, 1 wt%, 1.5 wt%, 2 wt%, 2.5 wt%, or even 5 wt%. The solvent may be present at a highest level of 95 wt%, 90 wt%, 85 wt%, 80 wt%, 70 wt%, 60 wt%, 50 wt%, 40 wt%, 30 wt%, 25 wt%, 20 wt%, or even 10 wt%. Any higher level of solvent is intended to be combinable with any lower level of solvent.
Preferably, the composition comprises one or more surfactants. The surfactant may be present at a level of from 0.25 to 25 wt%, preferably from 0.25 to 20 wt%, more preferably from 0.25 to 15 wt%, even more preferably from 0.25 to 10 wt%, or even from 0.5 to 10 wt% or even from 0.5 to 5 wt%.
The surfactant may be present at a level of from 0.25 to 25 wt%, preferably from 0.25 to 20 wt%, more preferably from 0.25 to 15 wt%, even more preferably from 0.25 to 10 wt%, or even from 0.5 to 10 wt% or even from 0.5 to 5 wt%.
The surfactant is preferably selected from anionic, nonionic, cationic and/or amphoteric surfactants. Preferred surfactants are nonionic surfactants.
The composition preferably comprises a buffer.
In a second aspect, the present invention relates to a method of treating a surface by treatment with a composition according to the first aspect of the invention to improve the resistance of the surface to bacterial contamination.
Preferably, the surface to be treated is selected from plastics, metals, wood, polymers, paper, fabrics and/or wipes.
Preferably, in the method, the lactam is selected from:
and/or +.>Preferably +.>
In a third aspect, the invention also relates to the use of a combination of a solvent in a lactam composition and a pH of 4-6.5, preferably 4-6.25, more preferably 4.50-6.00 applied to the composition for improving the solubility and stability of the lactam in the composition.
Preferably, in said use, the lactam is selected from:
and/or +.>Preferably +.>
Drawings
Fig. 1 is a photograph showing the solubility of lactam 488 at pH 5, pH 7 and pH 8.
Figure 2 shows the effect of pH on the solubility and stability of lactam 488. The initial solubility (left hand axis and rounded data points) and stability (right hand axis and square data points) of the lactam was delivered in ethanol to a total of 2% solvent and 100ppm lactam in solution vs buffer pH.
Detailed Description
The indefinite articles "a" or "an" and their corresponding definite articles "the" as used herein mean at least one, or one or more, unless otherwise specified.
It should be understood that all preferences are combinable unless explicitly stated otherwise.
Lactam
The lactam is a cyclic amide. The lactam is a lactam selected from the group consisting of:
more preferably, the lactam is selected from:
and/or +.>
Most preferably, the lactam is:
(4-chlorophenyl) -5-methylene-pyrrol-2-one.
When the lactam is cationic in nature, it may be used either as a cation or with a suitable counter ion (e.g. iodide).
Lactam level
Preferably the lactam is present at a level of 0.0001 to 2.5 wt%, preferably 0.0001 to 1 wt%. For example, the lactam may suitably be present at a level of 0.001 to 1 wt%, or even 0.01 to 0.5 wt%.
Composition and method for producing the same
Preferably, the lactam is delivered from a water-based composition, preferably it comprises 0.1 to 98 wt%, preferably 0.5 to 80 wt%, more preferably 1 to 75 wt% water. The composition may comprise any amount of water ranging from a lower amount of 0.1, 0.5, 1, 1.5, 2 or even 5 wt% water up to 30, 40, 50, 60, 70, 75, 80, 85, 90, 95, 96, 97, 98 or even 99 wt% water.
Solvent(s)
The composition comprises a solvent.
Preferred solvents are selected from: an alcohol; levulinate derivatives; lactic acid ester derivatives; and a solvent having a dielectric constant of 15 or more. Preferred examples of solvents are: alcohols, preferably C1-C4 alcohols, more preferably ethanol; lactate derivatives, preferably ethyl lactate and/or butyl lactate; levulinate derivatives, preferably 2-methyltetrahydrofuran, ethyl levulinate and/or ethyl Levulinate Glycerol Ketal (LGK); and a solvent having a dielectric constant of 15 or more, preferably Dimethylsulfoxide (DMSO).
Preferably, the solvent is selected from: ethanol; ethyl lactate, butyl lactate; 2-methyltetrahydrofuran (2 Me-THF), ethyl levulinate and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
Preferably, the solvent is selected from: levulinate derivatives; and lactate derivatives.
Most preferably, the solvent is selected from: ethyl lactate, butyl lactate; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
2Me-THF, ethyl levulinate, and LGK can be categorized as levulinate derivatives (or levulinate derivatives). Levulinic acid can be derived from lignocellulosic biomass (i.e., corn hulls, bagasse, etc.), and can be converted to 2Me-THF in a cyclization reaction, ethyl levulinate in a one-step esterification, and LGK in two steps (esterification and ketal synthesis).
Ethyl lactate and butyl lactate are lactic acid (lactate) derivatives. Lactic acid is a byproduct of fermentation, which is then reacted with ethanol or butanol to produce ethyl lactate and butyl lactate.
The solvent is present at a level of 0.5 to 95 wt%, preferably 0.5 to 90 wt%, more preferably 0.5 to 80 wt%. The solvent may be present at a minimum level of 0.5 wt%, 0.75 wt%, 1 wt%, 1.5 wt%, 2 wt%, 2.5 wt%, or even 5 wt%. The solvent may be present at a highest level of 95 wt%, 90 wt%, 85 wt%, 80 wt%, 70 wt%, 60 wt%, 50 wt%, 40 wt%, 30 wt%, 25 wt%, 20 wt%, or even 10 wt%. Any higher level of solvent is intended to be combinable with any lower level of solvent.
The solvent may be present at a level of from 1 to 80 wt%, preferably from 1 to 50 wt%, more preferably from 1 to 40 wt%. The solvent level may also be 1 to 30 wt%, 1 to 20 wt%, or even 1 to 15 wt% or 1 to 10 wt%.
Preferably, the composition comprises one or more surfactants. The surfactant may be present at a level of from 0.25 to 25 wt%, preferably from 0.25 to 20 wt%, more preferably from 0.25 to 15 wt%, even more preferably from 0.25 to 10 wt%, or even from 0.5 to 10 wt% or even from 0.5 to 5 wt%.
The surfactant is preferably selected from anionic, nonionic, cationic and/or amphoteric surfactants. Preferred surfactants are nonionic surfactants.
The composition may preferably comprise a buffer to help maintain any resulting composition within a specified pH range. The buffer system may be any conventional buffer system known in the art. These may include, for example, citrate, acetate, phosphate and/or carbonate buffers, or mixtures thereof.
Further ingredients
The composition may comprise further ingredients such as surfactants, chelating agents, thickeners, pH modifiers and perfumes.
The invention will be further described by the following non-limiting examples.
Examples
Example 1 preparation of preferred lactam examples
Preparation of 4- (4-chlorophenyl) -5-hydroxy-5-methylfuran-2 (5H) -one
1- (4-chlorophenyl) propan-2-one (40.00 g,34.75mL,237.2 mmol), glyoxylate monohydrate (32.75 g,355.8 mmol) and phosphoric acid (69.74 g,711.7 mmol) were combined at room temperature and then heated to 85℃overnight. After cooling to room temperature, the mixture was poured into a mixture of water (500 mL) and ethyl acetate (500 mL). The layers were separated and the aqueous phase was extracted with ethyl acetate (500 mL). The combined organic layers were washed with a 1:1 mixture of water and brine (2×500 mL), dried (MgSO 4 ) And concentrated under reduced pressure to give 4- (4-chlorophenyl) -5-hydroxy-5-methylfuran-2 (5H) -one (66.00 g,>100% yield) as brown oilA shape. This material was used in the next step without further purification.
Preparation of 4- (4-chlorophenyl) -5-hydroxy-5-methyl-1H-pyrrol-2 (5H) -one
4- (4-chlorophenyl) -5-hydroxy-5-methylfuran-2 (5H) -one (66.00 g,293.8 mmol) was dissolved in thionyl chloride (196.8 g,120.0mL,1654 mmol) and heated at 40℃for 1 hour, then at 80℃for 2 hours. The mixture was concentrated under reduced pressure and azeotroped with 2-methyltetrahydrofuran (200 mL). The residue was diluted with 2-methyltetrahydrofuran (160 mL) and the solution was added to a cooled stirred mixture of 28% aqueous ammonia (180 mL) in 2-methyltetrahydrofuran (20 mL) at 0 ℃. The mixture was warmed to room temperature and stirred overnight. Water (100 mL) and ethyl acetate (200 mL) were added and the layers separated. The aqueous phase was extracted with ethyl acetate (200 mL) and the combined organic extracts were dried (MgSO 4 ) And concentrated under reduced pressure. Purification by dry flash column chromatography (5-60% ethyl acetate in heptane) afforded 4- (4-chlorophenyl) -5-hydroxy-5-methyl-1H-pyrrol-2 (5H) -one (23.18 g,35% yield) as a cream solid.
1 H NMR(400MHz,d 6 -DMSO)8.55(brs,1H),7.88-7.83(m,2H),7.51-7.46(m,2H),6.37(d,1H),6.32(s,1H),1.45(s,3H)
UPLC (alkaline) 1.51/5.00min,100% purity, M+H + 224
MP 177℃
Preparation of 4- (4-chlorophenyl) -5-methylene-1H-pyrrol-2 (5H) -one
To a cooled solution of 4- (4-chlorophenyl) -5-hydroxy-5-methyl-1H-pyrrol-2 (5H) -one (10.00 g,44.51 mmol) in anhydrous dichloromethane (100 mL) at 0deg.C for 15 min was added boron trifluoride etherate (8.213 g,7.142 mL)57.87 mmol) in anhydrous dichloromethane (45 mL). The mixture was stirred at 0 ℃ and then slowly warmed to room temperature and stirred for 2 hours. The reaction was quenched with ice water (100 mL) and the layers separated. The aqueous layer was extracted with dichloromethane (100 mL) and the combined organic layers were washed with a 1:1 mixture of water and saturated aqueous sodium bicarbonate (100 mL), dried (MgSO 4 ) And filtered. Silica was added to the filtrate and the mixture was stirred for 10 minutes, then filtered through a plug of silica, washed thoroughly with dichloromethane, then with a 3:1 mixture of dichloromethane and diethyl ether. . Fractions containing the desired product were combined and concentrated under reduced pressure. A precipitate formed upon concentration, which was collected by filtration, and washed with diethyl ether to give 4- (4-chlorophenyl) -5-methylene-1H-pyrrol-2 (5H) -one (5.25 g,57% yield) as a cream solid.
1 H NMR(400MHz,d 6 -DMSO)10.10(s,1H),7.54-7.47(m,4H),6.36(s,1H),5.04(t,1H),4.85(s,1H)
UPLC (alkaline) 1.87/5.00min,100% purity, M+H + 206
MP 182℃
Preparation of 5-hydroxy-5-methyl-4- (p-tolyl) furan-2 (5H) -one
1- (p-tolyl) propan-2-one (25.00 g,24.00mL,168.7 mmol), glyoxylate monohydrate (23.29 g,253.0 mmol) and phosphoric acid (49.60 g,506.1 mmol) were combined at room temperature and then heated overnight at 90 ℃. After cooling to room temperature, the mixture was poured into a stirred mixture of ice water (400 mL) and ethyl acetate (400 mL). The layers were separated and the organic phase was washed with water (100 mL), dried (MgSO 4 ) And concentrated under reduced pressure. The mixture was azeotroped with 2-methyltetrahydrofuran (50 mL) to give 5-hydroxy-5-methyl-4- (p-tolyl) furan-2 (5H) -one (16.50 g,48% yield) as a brown solid.
1 H NMR(400MHz,d 6 -DMSO)7.86(s,1H),7.75(d,2H),7.28(d,2H),6.59(s,1H),2.32(s,3H),1.61(s,3H)
Preparation of 5-hydroxy-5-methyl-4- (p-tolyl) -1H-pyrrol-2 (5H) -one
5-hydroxy-5-methyl-4- (p-tolyl) furan-2 (5H) -one (16.50 g,80.80 mmol) was dissolved in thionyl chloride (48.06 g,29.47mL,404.0 mmol) and heated at 50℃for 1 hour, then at reflux for 1 hour. After cooling to room temperature, the mixture was concentrated under reduced pressure and azeotroped with 2-methyltetrahydrofuran (2×50 mL). The residue was diluted with 2-methyltetrahydrofuran (60 mL) and the solution was added at 0deg.C to a cooled stirred mixture of 28% aqueous ammonia (55 mL,808.0 mol) in 2-methyltetrahydrofuran (10 mL). The mixture was warmed to room temperature and stirred overnight. The 2-methyltetrahydrofuran was removed under reduced pressure, the residue was diluted with water (200 mL) and diethyl ether (100 mL), and the mixture was stirred at room temperature for 20 min. The solid was collected by filtration and stirred at room temperature in water (100 mL) and diethyl ether (50 mL) for 10 min. The solid was collected by filtration, washed with water, diethyl ether, and dried under vacuum at 50 ℃ to give 5-hydroxy-5-methyl-4- (p-tolyl) -1H-pyrrol-2 (5H) -one (10.49 g,31% yield) as a pale beige solid.
1 H NMR(400MHz,d 6 -DMSO)8.44(brs,1H),7.73(d,2H),7.21(d,2H),6.24(s,2H),2.29(s,3H),1.45(s,3H)
13 C NMR(400MHz,d 6 -DMSO)170.4(s,1C),161.1(s,1C),139.8(s,1C),129.7(s,2C),128.9(s,1C),128.2(s,2C),119.1(s,1C),87.8(s,1C),26.7(s,1C),21.5(s,1C)
UPLC (alkaline) 1.41/5.00min,100% purity, M+H + 204
MP 178 ℃ decomposition
Preparation of 5-methylene-4- (p-tolyl) -1H-pyrrol-2 (5H) -one
To a cooled solution of 5-hydroxy-5-methyl-4- (p-tolyl) -1H-pyrrol-2 (5H) -one (8.68 g,42.7 mmol) in anhydrous dichloromethane (87 mL) was added a solution of boron trifluoride etherate (6.85 g,5.96mL,55.5 mmol) in anhydrous dichloromethane (40 mL) at 0deg.C over 15 min. After 1 hour, the mixture was allowed to slowly warm to room temperature. After a further 3 hours, the reaction was diluted with dichloromethane (50 mL) and ice water (100 mL) and stirred for 10 minutes. The layers were separated and the organic layer was washed with water (100 mL), a 1:1 mixture of water and saturated aqueous sodium bicarbonate (100 mL) and brine (100 mL) and the organic layer was filtered through celite, washing with dichloromethane. Any excess water was removed by pipette and the filtrate was dried (MgSO 4 ) And concentrated under reduced pressure to a brown solid. The solid was stirred in hot dichloromethane (120 mL) for 15 min, then slowly cooled to room temperature, and then cooled to 0 ℃. The solid was collected by filtration to give 5-methylene-4- (p-tolyl) -1H-pyrrol-2 (5H) -one (3.87 g,49% yield) as a yellow solid. Silica was added to the filtrate and the mixture was stirred for 10 minutes, then filtered through a plug of silica, washed thoroughly with dichloromethane, then with a 4:1 mixture of dichloromethane and diethyl ether. The filtrate was concentrated under reduced pressure to give 5-methylene-4- (p-tolyl) -1H-pyrrol-2 (5H) -one (0.58 g, 7%) as a yellow solid. Total yield of 5-methylene-4- (p-tolyl) -1H-pyrrol-2 (5H) -one (4.45 g,56% yield).
1 H NMR(400MHz,d 6 -DMSO)10.11(brs,1H),7.35(d,2H),7.25(d,2H),6.25(s,1H),5.01(s,1H),4.85(s,1H),2.31(s,3H)
UPLC (alkaline) 1.83/5.00min,100% purity, M+H + 186
MP 200 ℃ decomposition
The materials used
In the examples below, lactam 488 is used.
This is 4- (4-chlorophenyl) -5-methylene-pyrrol-2-one and the structure is shown below: -
Example 2
This example shows the effect of pH on the solubility of a lactam in a water-based composition comprising a solvent. A stock solution of lactam 488 at a target 10000ppm in ethanol was prepared and placed on a bottle roller (bottle roller) for 24 hours, then filtered through a syringe filter to produce a saturated solution (possibly about 8000ppm in ethanol). The stock solution was mixed with 0.1M acetate buffer at pH 5.2 or with 0.1M phosphate buffer at pH 7 or 8 in a ratio of 1:2, stirred in a vial and any precipitate formed was observed visually, indicating insolubility. From fig. 1 (glass picture) it can be seen that the lactam is mostly dissolved to an acceptable level at pH 5, whereas the solubility is greatly reduced at pH 7 and 8.
Example 3
This example demonstrates the lack of stability of the lactam composition at a pH below pH 4 and above pH 6.5.
Initial lactam solubility (3 hours) was measured by preparing a 5mg/ml solution of lactam 488 in ethanol. A 0.1M phosphate/citrate/carbonate mixed buffer was prepared and adjusted to a pH range of 2-10 (precise values in fig. 2 and table 1), then lactam 488/EtOH stock solution was added to a total of 2%, corresponding to the theoretical 100ppm lactam concentration in solution.
The solution was equilibrated for 3 hours, and then 200 μl of 7 replicates each was dispensed into a 96-well microtiter plate (Greiner, UV-Star), with well 8 as a background free of lactam. UV absorbance spectra were recorded in the range of 200-450nm on a Varioskan Lux UV/Vis plate reader to quantify the intensity of the lactam peak (lambda max =280 nm) and the signal was converted to ppm lactam in solution for calibration of the known EtOH/lactam solution.
Using a solution state 1 H NMR measured long term lactam stability. Lactam 488 was dissolved to a maximum concentration (10 mg/mL) in d6-DMSO and combined at a ratio of 2:1 with a series of pH buffers (pH 7.4.0.2M phosphate buffer, pH 6.1M citrate buffer, pH 5.2.0.1M acetate buffer)4, 2) and water. These samples were then filtered and inhibited by water 1 H NMR was studied at weekly time points for 4 weeks. The integration of the buffer peak was used to quantify the relative% of residual lactam compared to the lactam resonance at 5.22 ppm.
Results of lactam stability and solubility are shown in FIG. 2 for UV/Vis and 1 h NMR data showed. The values in fig. 2 are also shown in table 1.
pH buffer Lactam concentration (3 hours) (ppm) % residual lactam (4 weeks)
2 >80* 20
3.12 80.53 ~30*
4.08 77.83 50
5.22 73.53 80
6.21 72.22 60
7.08 67.90 20
8.05 67.68 <10*
8.92 68.43 5
9.84 63.17 <5*
Table 1 initial concentrations calculated using UV/Vis spectroscopy, attenuation measured by NMR spectroscopy-values with x were not measured, but estimated by extrapolation from the plot
For compositions in which the pH is 4-6.5, the lactam only initially dissolves and exhibits long-term stability (4 weeks). Above this pH, the composition is not sufficiently soluble and is also unstable, while below pH 4, the composition is unstable.

Claims (14)

1. A composition comprising:
(a) 0.0001 to 5 wt%, preferably 0.0001 to 2.5 wt%, more preferably 0.0001 to 1 wt%, and even more preferably 0.001 to 1 wt% of a lactam; and
(b) 1 to 80 wt%, preferably 1 to 50 wt%, more preferably 1 to 40 wt% of a solvent;
wherein the composition has a pH of from 4 to 6.50, preferably from 4 to 6.25, more preferably from 4.50 to 6.00;
wherein the lactam is selected from the group consisting of:
and +.>
2. The composition according to claim 1, wherein the pH is 4-5.40, preferably 4.50-5.40.
3. The composition of claim 1 or claim 2, wherein the lactam is selected from the group consisting of:
and/or +.>
4. The composition of any one of the preceding claims, wherein the lactam is:
4- (4-chlorophenyl) -5-methylene-pyrrol-2-one.
5. The composition according to any of the preceding claims, wherein the composition is a water-based composition, preferably comprising 0.1 to 98 wt%, preferably 0.5 to 80 wt%, more preferably 1 to 75 wt% water.
6. The composition of any of the preceding claims, wherein the solvent is selected from the group consisting of: an alcohol; levulinate derivatives; lactic acid ester derivatives; and a solvent having a dielectric constant of 15 or more; preferably the solvent is: alcohols, preferably C1-C4 alcohols, more preferably ethanol; lactate derivatives, preferably ethyl lactate and/or butyl lactate; levulinate derivatives, preferably 2-methyltetrahydrofuran, ethyl levulinate and/or ethyl Levulinate Glycerol Ketal (LGK); and a solvent having a dielectric constant of 15 or more, preferably Dimethylsulfoxide (DMSO).
7. The composition of any of the preceding claims, wherein the solvent is selected from the group consisting of: ethanol; ethyl lactate, butyl lactate; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof; ethyl lactate and butyl lactate are preferred; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
8. The composition of any of the preceding claims, wherein the solvent is selected from the group consisting of: ethyl lactate, butyl lactate; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
9. The composition of any one of the preceding claims, wherein the composition comprises a buffer system.
10. A method of treating a surface by treatment with a composition according to any one of claims 1 to 9 to improve the resistance of the surface to bacterial fouling.
11. The method according to claim 10, wherein the surface to be treated is selected from plastic, metal, wood, polymer, paper, fabric and/or wipe.
12. The method of claim 10 or claim 11, wherein the lactam is selected from the group consisting of:
and/or +.>Preferably +.>
13. Use of a combination of a solvent in a lactam composition and a pH of 4-6.50 applied to the composition, preferably a pH of 4-6, more preferably a pH of 4.50-5.50, for improving the solubility and stability of the lactam in the composition.
14. The use according to claim 14, wherein the lactam is selected from the group consisting of:
and/or +.>Preferably +.>
CN202180081479.4A 2020-12-09 2021-11-05 Lactam composition and use Pending CN116648138A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20212740.3 2020-12-09
EP20212740 2020-12-09
PCT/EP2021/080767 WO2022122265A1 (en) 2020-12-09 2021-11-05 Lactam composition and use

Publications (1)

Publication Number Publication Date
CN116648138A true CN116648138A (en) 2023-08-25

Family

ID=73789919

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180081479.4A Pending CN116648138A (en) 2020-12-09 2021-11-05 Lactam composition and use

Country Status (3)

Country Link
EP (1) EP4258868A1 (en)
CN (1) CN116648138A (en)
WO (1) WO2022122265A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009069006A2 (en) * 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
DE212014000038U1 (en) * 2013-02-01 2015-09-21 Unilever N.V. composition
US10306886B2 (en) * 2015-08-20 2019-06-04 Conopco Inc. Lactam solubility
EP3849500A1 (en) * 2018-09-14 2021-07-21 Unilever Global Ip Limited Mousse composition

Also Published As

Publication number Publication date
WO2022122265A1 (en) 2022-06-16
EP4258868A1 (en) 2023-10-18

Similar Documents

Publication Publication Date Title
EP3337451B1 (en) Improved lactam solubility
EP2607363B1 (en) Fused ring compound for use as mineralocorticoid receptor antagonist
WO2017029112A1 (en) Lactam compositions
WO1999043678A1 (en) Remedies/preventives for parkinson&#39;s disease
DE60314730T2 (en) USE OF 4-AMINOPYRIMIDINES FOR ANTIMICROBIAL TREATMENT OF SURFACES
CN112689497B (en) Mousse composition
CN116648138A (en) Lactam composition and use
JP4986110B2 (en) Melanin production inhibitor containing resorcinol derivative
CN109153683A (en) 2H- chromene as NF- kB inhibitor simultaneously [2,3-D] pyrimidine -2,4 (3H)-diketone
KR20070042206A (en) Method for manufacturing enantiomeric imidazole compounds
EP3337450B1 (en) Improved lactam solubility
CN116669553A (en) Lactam composition and use
EP3877471B1 (en) Method of treatment of a surface
EP3385260A1 (en) Novel hydroxyl pyranone compound, method for producing same, and cosmetics composition comprising compound
US11401240B2 (en) Process for the synthesis of lactams
CN116583180A (en) Lactam composition and use
CN112689664A (en) Wiping article
EP3337449B1 (en) Improved lactam solubility
KR100500503B1 (en) Process for preparing a crystal 3-0-alkyl ascorbic acid
KR101625784B1 (en) Ascorbic acid derivative composition and method for producing same, ascorbic acid derivative solution, and external preparation for skin
EP2885297B1 (en) Trisubstituted pyrido[3,2-d]pyrimidines, their preparation process and their therapeutical uses
US10377707B2 (en) Process for the preparation of lactams from glyoxalic acid
EP3712149B1 (en) Benzamide derivative compound, method for preparing same, and pharmaceutical composition for treating or preventing inflammatory disease containing same as active ingredient
JP2005343964A (en) Aqueous solution containing polyalkylene glycol and method for preparing the same
KR101569341B1 (en) 4-(Arylureido)pyrrolidine derivatives inhibiting beta-secretase&#39;s activity and pharmaceutical composition containing the same as an active ingredient

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination